Clinical Report: Assessment of Health-Related Quality of Life in Chinese Pediatric Patients
Overview
This study evaluates health-related quality of life (HRQoL) in Chinese children with newly diagnosed immune thrombocytopaenia (ITP) using the Kids’ ITP Tools (KITs) scale. It reveals significant parent-child discrepancies in HRQoL scores.
Background
Immune thrombocytopaenia (ITP) is an autoimmune disorder that can significantly impact the quality of life in pediatric patients. Understanding HRQoL in newly diagnosed children is crucial, as existing studies often focus on chronic cases and use generic assessment tools. This study addresses a gap in longitudinal HRQoL data for the Chinese pediatric population.
Data Highlights
Measure
Findings
Parent-child discordance in HRQoL scores
Mean difference 20.06 points at diagnosis (p<0.001)
Scale reliability
Parent α=0.944, Child α=0.910
Association with baseline platelet counts
No association (all p>0.05)
HRQoL reductions
Transient reductions following bone marrow aspiration and glucocorticoid therapy
Age-specific patterns
Older children reported greater family-related distress (p=0.044)
Key Findings
Significant parent-child discordance in HRQoL scores at diagnosis.
Excellent reliability of the KITs scale for both parents and children.
No correlation between baseline platelet counts and HRQoL.
Transient reductions in HRQoL following medical procedures.
Age-specific differences in reported distress levels between parents and children.
Clinical Implications
The findings highlight the importance of using the Kids’ ITP Tools scale in clinical practice to understand the HRQoL of pediatric ITP patients.
Conclusion
This study validates the use of the KITs scale in assessing HRQoL in pediatric ITP and highlights significant discrepancies in reporting between parents and children.
